Inequality shaping health outcomes, and how poor people are disproportionately affected by infectious diseases – these are driving passions for Cape Town epidemiologist Alex de Voux.
Scientists worldwide are sounding the alarm at the return of syphilis, describing the comeback of the easily preventable infection as a huge public health failing – as an effective vaccine remains elusive.
Condom distribution in South Africa has dropped dramatically over the last five years, finds a Spotlight analysis of data recently published in the Health System Trust’s District Health Barometer.
There’s a resurgence of sexually transmitted infections (STIs) in South Africa and around the world. The Gauteng Department of Health recently reported an increase of newly acquired STIs, in particular gonorrhoea and chlamydia. This spike in cases call for management guidelines and awareness programmes to be reviewed, reports Ufrieda Ho.
Taking the antibiotic doxycycline after condomless sex can reduce the risk of contracting three different sexually transmitted infections (STIs), according to a study presented last week at the AIDS 2022 conference in Montreal, Canada. Elri Voigt unpacks the study findings and asks local experts what it might mean for combatting STIs in South Africa.
In 2014, South Africa launched an HPV vaccination campaign targeting 9-year-old public school learners in Grade 4. It involves delivering two doses of vaccine six months apart. Laura Owings asks how the campaign is going and what recent real-world HPV vaccine effectiveness data from the United Kingdom might mean for South Africa.
Over the last few years reported cases of congenital syphilis in South Africa have increased. This, accompanied by little or lack of notification, makes its management a challenge. Tiyese Jeranji reports on what congenital syphilis is, its management as well as gaps in management.
Despite the global emergence of highly resistant strains of gonorrhoea, including untreatable variants, a new antibiotic for the disease has not been developed in over half a century. In January, a trial began in South Africa and other countries for a new gonorrhoea antibiotic. But what is gonorrhoea? How significant is the problem in South Africa and among those living with HIV? Do we have resistant strains too? Experts report a grim situation, but with hope on the horizon. Amy Green reports.
